🇺🇸 FDA
Patent

US 6608067

Inhibitors of serine proteases, particularly HCV NS3 protease

expired A61PA61P1/16A61P31/12

Quick answer

US patent 6608067 (Inhibitors of serine proteases, particularly HCV NS3 protease) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/16, A61P31/12, A61P31/14, A61P31/18